INSIGHTS ON CELL & GENE CLINICAL TRIALS
-
![Heart-Attack-heart-disease-GettyImages-1359314170]( "XyloCor’s Phase 2 EXACT Trial Success")
XyloCor’s Phase 2 EXACT Trial SuccessXyloCor Therapeutics’ CEO, Albert Gianchetti provides updates about the clinical-stage biopharma’s EXACT clinical trial.
-
![gettyimages-1273886962 therapeutics]( "Navigating Regulatory Pathways For Digital Therapeutics")
Navigating Regulatory Pathways For Digital TherapeuticsThis blog post will help sponsors gain clarity regarding what is and what is not considered a DTx and how to ensure they are following the correct regulatory pathway for their device.
-
![gettyimages-1368252357 patient enrollment]( "Seasonality: A Factor For Successful Patient Recruitment")
Seasonality: A Factor For Successful Patient RecruitmentManaging clinical trials requires extensive planning of patient enrollment. Clinical trials may be more cost-effective with better forecasts of recruitment.
-
![gettyimages-1379807329 therapeutics]( "The Rise Of Radiotherapeutics: Brief History And Best Practices For Clinical Trials")
The Rise Of Radiotherapeutics: Brief History And Best Practices For Clinical TrialsExplore a brief history of radiopharmaceuticals and discover best practices for planning and executing clinical trials utilizing these novel drugs to treat cancer.
-
![Laboratory-analysis-GettyImages-1385463753]( "Astellas Pharma: Moving On from Clinical Hold")
Astellas Pharma: Moving On from Clinical HoldHa Tran, Executive Medical Director at Astellas Pharma, explains the cause of the clinical hold and the future of the program now that the hold has been lifted.
-
![FDA headquarter iStock-1213293784]( "FDA Releases Final Guidance On Early-Phase Cell & Gene Therapy Trials")
FDA Releases Final Guidance On Early-Phase Cell & Gene Therapy TrialsThe cell and gene therapy development process involves screening different variants of a product type. To aid this process and to ensure that suitable evidence is gathered so that effective variants of the product are taken through to later-stage trials, the FDA has produced a final guidance, Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial.
-
![eye-concept-iStock-1046702918]( "C3 Glomerulopathy: The Asia Pacific Clinical Trial Landscape")
C3 Glomerulopathy: The Asia Pacific Clinical Trial LandscapeC3 Glomerulopathy (C3G) is a complex, rare complement-mediated renal disease. Find out its effects in the Asia Pacific.
-
![only-diabetes]( "Diabetic Retinopathy: The Asia Pacific Clinical Trial Landscape")
Diabetic Retinopathy: The Asia Pacific Clinical Trial LandscapeDiabetic Retinopathy (DR) is the leading cause of vision loss in working-age populations, and one of the main complications of Diabetes Mellitus (DM). Read about the effects of this disease.
-
![Next Generation OCT Systems For Glaucoma Diagnosis]( "Glaucoma: Asia Pacific Clinical Trial Landscape")
Glaucoma: Asia Pacific Clinical Trial LandscapeThe world is heavily burdened by glaucoma, which is the second-leading cause of blindness and the primary cause of irreversible blindness. Learn about its effects in the Asia Pacific.
-
![Training Beyond Onboarding: Filling The Gaps In Food Manufacturing]( "Peanut Allergy: Asia Pacific Clinical Trial Landscape")
Peanut Allergy: Asia Pacific Clinical Trial LandscapeExplore the differences between the common food allergies in Asia and the West, specifically the peanut allergy.
